These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18550825)

  • 1. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway.
    Liang S; Ristich V; Arase H; Dausset J; Carosella ED; Horuzsko A
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8357-62. PubMed ID: 18550825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
    Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
    Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerization of dendritic cells by HLA-G.
    Ristich V; Liang S; Zhang W; Wu J; Horuzsko A
    Eur J Immunol; 2005 Apr; 35(4):1133-42. PubMed ID: 15770701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells.
    Ristich V; Zhang W; Liang S; Horuzsko A
    Hum Immunol; 2007 Apr; 68(4):264-71. PubMed ID: 17400062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells.
    Wu J; Horuzsko A
    Hum Immunol; 2009 May; 70(5):353-6. PubMed ID: 19405174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
    Gregori S; Magnani CF; Roncarolo MG
    Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G.
    Liang S; Horuzsko A
    Hum Immunol; 2003 Nov; 64(11):1025-32. PubMed ID: 14602231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
    Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
    J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of immunolglobulin-like transcript family receptors and their ligands in suppressor T-cell-induced dendritic cell tolerization.
    Chui CS; Li D
    Hum Immunol; 2009 Sep; 70(9):686-91. PubMed ID: 19524004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the exopolysaccharide from an anamorph of Cordyceps sinensis on dendritic cell sarcoma (DCS) cell line.
    Song D; He Z; Wang C; Yuan F; Dong P; Zhang W
    Eur J Nutr; 2013 Mar; 52(2):687-94. PubMed ID: 22610670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells.
    Ohno Y; Kitamura H; Takahashi N; Ohtake J; Kaneumi S; Sumida K; Homma S; Kawamura H; Minagawa N; Shibasaki S; Taketomi A
    Cancer Immunol Immunother; 2016 Feb; 65(2):193-204. PubMed ID: 26759006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance.
    Wu J; Zhang W; Hernandez-Lopez P; Fabelo E; Parikh M; Mulloy LL; Horuzsko A
    Hum Immunol; 2009 Dec; 70(12):988-94. PubMed ID: 19664670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
    Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
    J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction of tolerogenic dendritic cells by membrane-bound HLA-G in vitro].
    Zhou H; Li WM; Zhang M; Liu ZR; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):369-72. PubMed ID: 17493349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1.
    McIntire RH; Morales PJ; Petroff MG; Colonna M; Hunt JS
    J Leukoc Biol; 2004 Dec; 76(6):1220-8. PubMed ID: 15459235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.
    Allan DS; Colonna M; Lanier LL; Churakova TD; Abrams JS; Ellis SA; McMichael AJ; Braud VM
    J Exp Med; 1999 Apr; 189(7):1149-56. PubMed ID: 10190906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-G-treated tolerogenic dendritic cells induce tolerogenic potential by increasing expression of B7-1 (CD80) molecules.
    Smith M; Bittner JG; White S; Smith D; Horuzsko A
    Transplant Proc; 2008 Jun; 40(5):1598-603. PubMed ID: 18589158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4.
    Köstlin N; Ostermeir AL; Spring B; Schwarz J; Marmé A; Walter CB; Poets CF; Gille C
    Eur J Immunol; 2017 Feb; 47(2):374-384. PubMed ID: 27859042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.
    Colonna M; Samaridis J; Cella M; Angman L; Allen RL; O'Callaghan CA; Dunbar R; Ogg GS; Cerundolo V; Rolink A
    J Immunol; 1998 Apr; 160(7):3096-100. PubMed ID: 9531263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.